Image

Global Prenatal Genetic Testing Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Prenatal Genetic Testing Market, By Technology {Diagnostics Methods, Screening Methods}, Screening Techniques (Carrier Screening, Sequential Screening, and Maternal Serum Quad Screening), Diseases (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers), Product (Products, Consumables, Assay Kits And ReagentsDisposables, Instruments, Next Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Ultrasound Devices, Other Instruments, Services) – Industry Trends and Forecast to 2029.

Prenatal Genetic Testing Market

Global Prenatal Genetic Testing Market Analysis and Size

Increased initiatives by the government to promote awareness about birth defects and genetic defects in the babies especially in the developing economies is boosting up the demand for prenatal genetic testing. United States, China, and Japan are extensively using the prenatal genetic testing technology which is now being followed by other emerging economies.                                         

  • Data Bridge Market Research analyses that the prenatal genetic testing market is expected to undergo a CAGR of 13.85% during the forecast period. This indicates that the market value, which was USD 8,722 million in 2021, would rocket up to USD 24,619.56 million by 2029. “Cancer” dominates the diseases segment of the prenatal genetic testing market owing to increasing incidences of cancer worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Prenatal Genetic Testing Market Definition

From the name itself, it is clear that prenatal genetic testing is a medical test which is conducted to diagnose all kinds of genetic difficulties or abnormalities before birth during the pregnancy. Prenatal genetic testing is useful in detecting the birth defects which basically arise out of hereditary and genetic disorders running in the family history.

Report Scope and Market Segmentation            

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Technology {Diagnostics Methods, Screening Methods}, Screening Techniques (Carrier Screening, Sequential Screening, and Maternal Serum Quad Screening), Diseases (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers), Product (Products, Consumables, Assay Kits And ReagentsDisposables, Instruments, NGS Systems, Polymerase Chain Reaction Instruments, Microarrays, Ultrasound Devices, Other Instruments, Services)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher. (US), BD (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), bioMérieux S.A. (France),  DiaSorin S.p.A (Italy), AccuBioTech Co., Ltd. (China), Meridian Bioscience (US), Biocartis Bioscience (Europe), GeneSTAT Molecular Diagnostics, LLC (US), Terumo Corporation (Japan) and Grifols, S.A (Spain)

Market Opportunities

  • Growth in the rate of pregnancy
  • Increasing incidence and prevalence of genetic ailments
  • Rising research and development opportunities

Prenatal Genetic Testing Market Dynamics

Drivers

  • Rising prevalence of genetic disorders

Growing incidence rate of genetic diseases and disorders is one of the major factors fostering the growth of the market. For example- increasing prevalence of diabetes running in the family history is directly influencing the market growth rate. Also, other genetic diseases such as Down syndrome, Edward syndrome, and Patau syndrome and rising geriatric population base vulnerable to chronic diseases will further create market opportunities.   

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the development of emergency healthcare services is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.

 Opportunities

Furthermore, upsurge in the public-private funding for target research activities, increasing demand for prenatal genetic testing for identifying genetic abnormalities and determining the sex of foetus, acquisition of small market applicants by leading players and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, growing application of genetic testing in oncology and genetic diseases in North America, consumer interest in personalized medicines in Europe, growing demand for direct-to-consumer genetic testing, rising internet penetration rate, and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Prenatal Genetic Testing Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, high cost of next generation sequencing, dependability of test results, especially in obese women and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This prenatal genetic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prenatal genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Prenatal Genetic Testing Market

COVID-19 has stimulated the market growth rate in the downward direction. The market was hit owing to the restrictions imposed by the government pertaining to the movement. Non-availability of genetic counsellors and their inability to physically check the patients derailed the market growth rate during this period. Predictive and presymptomatic testing segment took a sharp decline owing to the shutdown of laboratories for this purpose. However, with the rising pregnancy rate and surging relaxations, the market is projected to bounce back.

Recent Developments

  • In September 2021, MedGenome Labs launched its direct-to-consumer category under the brand name Genessense which will offer specialized, evidence-based genetic screening tests that can be ordered online through the Genessense website or via e-commerce platforms in the future.
  • In July 2021, Avellino Labs announced the launch of AvaGen, the Genetic Eye Test, in the United States which is designed to help determine a patient's risk of keratoconus and other corneal dystrophies.

Global Prenatal Genetic Testing Market Scope

The prenatal genetic testing market is segmented on the basis of technology, screening techniques, diseases, end user and product. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology  

  • Diagnostics Methods
  • Screening Methods

Based on the technology, the prenatal genetic testing market is segmented into diagnostics methods, screening methods. Diagnostics methods are further sub segmented into polymerase chain reaction, array comparative genomic hybridization (aCGH) and fluorescence in situ hybridization (FISH). Screening methods is further sub segmented into non-invasive prenatal tests, maternal serum screening.

Screening techniques

  • Carrier Screening
  • Sequential Screening
  • Maternal Serum Quad Screening

Based on the screening techniques, the prenatal genetic testing market is segmented into carrier screening, sequential screening, and maternal serum quad screening.

Diseases  

  • Alzheimer’s Disease
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington’s Disease
  • Rare Diseases
  • Other Diseases

Based on the diseases, the prenatal genetic testing market is segmented into  Alzheimer ’s disease, cancer, cystic fibrosis, sickle cell anemia, duchenne muscular dystrophy, thalassemia, huntington’s disease, rare diseases, other diseases.

End user

  • Hospitals
  • Clinics
  • Diagnostic Centers 

Based on the end user, the prenatal genetic testing market is segmented into hospitals, clinics and diagnostic centers.

Product

  • Products
  • Consumables
  • Assay Kits and Reagents
  • Disposables
  • Instruments
  • Next Generation Sequencing Systems
  • Polymerase Chain Reaction Instruments
  • Microarrays
  • Ultrasound Devices
  • Other Instruments
  • Services

Based on the product, the prenatal genetic testing market is segmented into products, consumables, assay kits and reagents, disposables, instruments, next generation sequencing systems, polymerase chain reaction instruments, microarrays, ultrasound devices, other instruments and services.

Prenatal Genetic Testing Market Regional Analysis/Insights

The prenatal genetic testing market is analysed and market size insights and trends are provided by country, technology, screening techniques, diseases, end user and product as referenced above.

The countries covered in the prenatal genetic testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the prenatal genetic testing market because of the strong base of healthcare facilities, presence of major players in this region, surging pregnancy rate and rising number of research activities in this region.  

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, availability of the well-established infrastructure rise in awareness toward early screening of genetic disorders and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The prenatal genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for prenatal genetic testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the prenatal genetic testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Prenatal Genetic Testing Market Share Analysis

The prenatal genetic testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to prenatal genetic testing market.

Some of the major players operating in the prenatal genetic testing market are:

  • Abbott (US)
  • Siemens Healthineers AG (Germany)
  • Quidel Corporation (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Danaher. (US)
  • BD (US)
  • Chembio Diagnostics (US)
  • EKF Diagnostics (UK)
  • Trinity Biotech plc (Ireland)
  • Instrumentation Laboratory (US)
  • Nova Biomedical (US)
  • PTS Diagnostics (US)
  • Sekisui Diagnostics (US)
  • Thermo Fisher Scientific (US)
  • bioMérieux S.A. (France)
  • DiaSorin S.p.A (Italy)
  • AccuBioTech Co., Ltd (China)
  • Meridian Bioscience (US)
  • Biocartis Bioscience (Europe)
  • GeneSTAT Molecular Diagnostics, LLC (US)
  • Terumo Corporation (Japan)
  • Grifols, S.A (Spain)

Research Methodology : Global Prenatal Genetic Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prenatal-genetic-testing-market

Customization Available : Global Prenatal Genetic Testing Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Prenatal Genetic Testing Market will be projected at USD 24,619.56 million during the forecast period of 2022 to 2029.
The Prenatal Genetic Testing Market is Projected to Grow at a CAGR of 13.85% During the Forecast Period of 2022 to 2029.
Abbott (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher. (US), BD (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), bioMérieux S.A. (France), DiaSorin S.p.A (Italy), AccuBioTech Co., Ltd. (China), Meridian Bioscience (US), Biocartis Bioscience (Europe), GeneSTAT Molecular Diagnostics, LLC (US), Terumo Corporation (Japan) and Grifols, S.A (Spain) are the Major Companies Operating in Prenatal Genetic Testing Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America are covered in the Prenatal Genetic Testing Market.
The Prenatal Genetic Testing Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.